Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
16 p, 2.1 MB Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease / Visser, Pieter Jelle (Karolinska Institutet (Estocolm, Suècia)) ; Reus, Lianne M. (Vrije Universiteit Amsterdam) ; Gobom, Johan (Sahlgrenska Academy at the University of Gothenburg) ; Jansen, Iris E (VU University) ; Dicks, Ellen (Vrije Universiteit Amsterdam) ; van der Lee, Sven J. (Vrije Universiteit Amsterdam) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans R. J. (Maastricht University) ; Popp, Julius (University Hospital Zurich (Suïssa)) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Vandenberghe, Rik (KU Leuven) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel) ; Freund-Levi, Yvonne (Örebro University) ; Froelich, Lutz (University of Heidelberg) ; Sleegers, Kristel (University of Antwerp) ; Dobricic, Valerija (University of Lübeck) ; Lovestone, Simon (High Wycombe, UK) ; Streffer, Johannes (AC Immune SA) ; Vos, Stephanie J. B. (Maastricht University) ; Bos, Isabelle (Maastricht University) ; Smit, August B. (Vrije Universiteit Amsterdam) ; Blennow, Kaj (Sahlgrenska Academy at the University of Gothenburg) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, Charlotte E. (Amsterdam University Medical Centers (AUMC)) ; Bertram, Lars (University of Oslo) ; Zetterberg, Henrik (Dementia Research Institute at UCL) ; Tijms, Betty M. (Vrije Universiteit Amsterdam) ; Universitat Autònoma de Barcelona
Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer's disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be increased in very early disease stages, when neurodegeneration is limited, and can be normal in advanced disease stages. [...]
2022 - 10.1186/s13024-022-00521-3
Molecular neurodegeneration, Vol. 17 (march 2022)  
2.
17 p, 1.3 MB Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics / Tijms, Betty M. (Vrije Universiteit Amsterdam) ; Gobom, Johan (Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg) ; Reus, Lianne (Vrije Universiteit Amsterdam) ; Jansen, Iris E (Vrije Universiteit Amsterdam) ; Hong, Shengjun (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Cardiogenetics, University of Lübeck) ; Dobricic, Valerija (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Cardiogenetics, University of Lübeck) ; Kilpert, Fabian (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Cardiogenetics, University of Lübeck) ; ten Kate, Mara (Vrije Universiteit Amsterdam) ; Barkhof, Frederik (Institutes of Neurology and Healthcare Engineering, UCL London) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans R. J. (Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University) ; Popp, Julius (Geneva University Hospitals (Suïssa)) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Vandenberghe, Rik (Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Engelborghs, Sebastiaan (Department of Neurology, UZ Brussel and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB)) ; Bertram, Lars (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Cardiogenetics, University of Lübeck) ; Lovestone, Simon (Janssen R&D) ; Streffer, Johannes (UCB Biopharma SPRL) ; Vos, Stephanie (Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University) ; Bos, Isabelle (Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University) ; Blennow, Kaj (Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, Charlotte E. (Neurochemistry laboratory, Department of Clinical Chemistry, Amsterdam UMC - location VUmc, Amsterdam Neuroscience) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit). UK Dementia Research Institute) ; Visser, Pieter Jelle (Karolinska Institutet (Estocolm, Suècia). Department of Neurobiology, Care Sciences and Society) ; Universitat Autònoma de Barcelona
Using CSF proteomics, Tijms et al. identify three Alzheimer's disease subtypes that show: 1) hyperplasticity and increased BACE1 levels; 2) innate immune activation; and 3) blood-brain barrier dysfunction with low BACE1 levels. [...]
2020 - 10.1093/brain/awaa325
Brain, Vol. 143 (november 2020) , p. 3776-3792  

Vegeu també: autors amb noms similars
1 Verhey, F.
1 Verhey, F. R. J.
1 Verhey, F.R.
2 Verhey, F.R.J.
9 Verhey, Frans
1 Verhey, Frans R.
3 Verhey, Frans R. J.
1 Verhey, Frans R.J.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.